Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2012
11/14/2012EP1707627B1 Antagonistic anti-CD40 antibody mutant
11/14/2012CN1717417B Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases
11/14/2012CN1668721B Immunoadhesin comprising a glycoprotein VI domain
11/14/2012CN102782499A Gastric cancer marker, and method for detecting gastric cancer
11/14/2012CN102782148A Antikine antibodies that bind to multiple CC chemokines
11/14/2012CN102782131A Modified antibody composition
11/14/2012CN102782129A Pharmaceutical composition
11/14/2012CN102781964A Anti-CDH3 antibodies and uses thereof
11/14/2012CN102781963A Function modifying Nav 1.7 antibodies
11/14/2012CN102781962A Biparatopic A-beta binding polypeptides
11/14/2012CN102781961A Hepatitis B virus specific antibody and uses thereof
11/14/2012CN102781959A Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
11/14/2012CN102781954A A cytolytic RTX-toxin from gallibacterium anatis
11/14/2012CN102778562A Cytotoxicity mediation of cells evidencing surface expression of CD44
11/14/2012CN102776200A Preparation method for monoclonal antibody
11/14/2012CN102776154A Mouse anti-human beta-Tubulin monoclonal antibody and hybridoma cell strain for secreting same
11/14/2012CN102776153A Mouse anti-human neutrophil gelatinase-associated lipocalin (NGAL) monoclonal antibodies and hybridoma cell strains and application thereof
11/14/2012CN102776152A Monoclonal antibody against BTV (bluetongue virus) VP7 protein, hybridoma cell strain capable of secreting monoclonal antibody and application of hybridoma cell strain
11/14/2012CN102776151A Monoclonal antibody for detecting aminoglycoside antibiotics and kit thereof
11/14/2012CN102775494A CD3 resistance/CD133 resistance bi-specific antibody and CIK (cytokine-induced killer) cells loaded by CD3 resistance/CD133 resistance bi-specific antibody
11/14/2012CN102775493A IL-1beta binding antibodies and fragments thereof
11/14/2012CN102775490A Secretory protein with migration activity and application thereof
11/14/2012CN102775486A Novel reagent and kit for renal injury monitoring
11/14/2012CN102775473A B cell epitope peptide of human neutrophil gelatinase associated lipocalin and application thereof
11/14/2012CN102775469A Antigen epitope of influenza A virus nucleocapsid protein, and its use
11/14/2012CN102772798A Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds
11/14/2012CN102399753B Specific monoclonal antibody of tilletia controversa kuhn and immunofluorescent detection method
11/14/2012CN102153651B Anti-dextran single-chain antibody and preparation method of anti-dextran single-chain antibody
11/14/2012CN102086230B Enzyme-linked immunosorbent assay kit for detecting melamine and application thereof
11/14/2012CN102086229B Method for detecting melamine and enzyme-linked immunosorbent assay kit special for same
11/14/2012CN102086228B ELISA (Enzyme Linked Immunosorbent Assay) Kit and application thereof
11/14/2012CN102060911B Polypeptide combined with various amyloid protein monomers simultaneously and application thereof
11/14/2012CN101914152B Mercury ion antigen and preparation method and application thereof
11/14/2012CN101892237B Polynucleotide related to mitochondrial membrane potential decrease and coded polypeptide and application thereof
11/14/2012CN101885773B Icariin monoclonal antibody and preparation method and application thereof
11/14/2012CN101864398B Monoclonal antibody of anti-gonadotropin-releasing hormone receptor and application thereof
11/14/2012CN101679518B The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
11/14/2012CN101445802B Novel porcine circovirus virus, vaccines and diagnosis agent
11/14/2012CN101379079B Peptide domain required for interaction between the envelope of a virus pertaining to the HERV-W interference group and an hASCT receptor
11/13/2012US8309693 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/13/2012US8309692 Antibodies to cytokine receptor ZCYTOR17
11/13/2012US8309691 Chlamydomonas intraflagellar transport 88 (IFT-88)
11/13/2012US8309690 Integrated approach for generating multidomain protein therapeutics
11/13/2012US8309684 Synthetic analogues of neural regeneration peptides
11/13/2012US8309315 Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods
11/13/2012US8309100 Nucleic acids and polypeptides specific of the Neisseria genus pathogenic strains
11/13/2012US8309094 Antibody-drug conjugates
11/13/2012US8309092 Wise binding agents and epitopes
11/13/2012US8309091 CEACAM8-related method for treating autoimmune diseases
11/13/2012US8309090 Monoclonal antibodies for neutralizing anthrax toxin
11/13/2012US8309087 Treatment with anti-ErbB2 antibodies
11/13/2012US8309084 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
11/13/2012US8309082 Anti-activin A antibodies and uses thereof
11/13/2012CA2641565C Nel-related proteins type 1 and 2, and polynucleotides encoding them
11/13/2012CA2549066C Diagnosing acute coronary syndrome by measuring levels of free papp-a
11/13/2012CA2526907C Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites
11/13/2012CA2478414C Selective targeting of tumor vasculature using antibody molecules
11/13/2012CA2454587C Stable lyophilized pharmaceutical formulation of igg antibodies
11/13/2012CA2359231C Methods and means for modification of plant characteristics using the vernalization gene vrn2
11/13/2012CA2344993C Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus
11/13/2012CA2326692C Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
11/11/2012CA2833866A1 Method for producing sheet-like pancreatic islet
11/08/2012WO2012151481A1 Compositions for inhibiting masp-2 dependent complement acitivation
11/08/2012WO2012150869A1 Antibodies that bind trefoil factors and methods of using same
11/08/2012WO2012150321A1 An antibody specifically binding to insulin-like growth factor-1
11/08/2012WO2012150320A1 Amino acid sequence presenting fusion polypeptide and its use
11/08/2012WO2012149653A1 Modulation of the sonic hedgehog pathway and uses thereof
11/08/2012WO2012125569A3 Anti-cd40 antibodies and uses thereof
11/08/2012WO2012119989A3 Antibodies against cadmi for the diagnosis and treatment of cancer
11/08/2012WO2012118813A3 Anti-il-6 receptor antibodies and methods of use
11/08/2012WO2012110968A3 Treatment of fistulizing crohn's disease
11/08/2012WO2012103260A3 High-throughput methods to produce, validate and characterize mmabs
11/08/2012WO2012033987A3 Anti-human folate receptor beta antibodies and methods of use
11/08/2012US20120283421 Methods and reagents for decreasing clinical reaction to allergy
11/08/2012US20120283419 Separation of protein monomers from aggregates by solid weak anion exchange support functionalized with amine moieties
11/08/2012US20120283418 Covalent disulfide-linked diabodies and uses thereof
11/08/2012US20120283417 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME
11/08/2012US20120283416 Wash solution and method for affinity chromatography
11/08/2012US20120283415 Multivalent Antibodies
11/08/2012US20120283414 Monoclonal Antibodies for Ebola and Marburg Viruses
11/08/2012US20120283126 Human fertility test using dpy19l2
11/08/2012US20120283113 Compositions and methods for antibody and ligand identification
11/08/2012US20120282701 Dna promoters and antrhax vaccines
11/08/2012US20120282638 Method for immunoassay of autoantibody against ku86, kit for use in same, and method for determination of primary hepatocellular carcinoma using same
11/08/2012US20120282637 Polypeptides for binding to the receptor for advanced glycation endproducts as well as compositions and methods involving
11/08/2012US20120282633 Antibody specific to activated egfr
11/08/2012US20120282612 Method for analyzing psa, and a method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing psa
11/08/2012US20120282593 Method and Kit for Detecting Virulent Strains of Influenza Virus
11/08/2012US20120282464 Spherical Protein Particles and Methods of Making and Using Them
11/08/2012US20120282289 Staphylococcal antigens
11/08/2012US20120282288 Recombinant Carrier Molecule for Expression, Delivery and Purification of Target Polypeptides
11/08/2012US20120282285 Masp isoforms as inhibitors of complement activation
11/08/2012US20120282280 Bi-specific digoxigenin binding antibodies
11/08/2012US20120282278 Anti p2x7 receptor antibodies and fragments thereof
11/08/2012US20120282277 Method for Treating Arteriosclerosis
11/08/2012US20120282274 Targeting of the c-terminal segment of c.difficile toxin b for improved clinical diagnosis, prevention, and treatment
11/08/2012US20120282273 Recombinant antibodies against h1n1 influenza
11/08/2012US20120282272 Novel target in the treatment of cytokine release syndrome
11/08/2012US20120282271 Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
11/08/2012US20120282269 Anti-IL-23 Antibodies